{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:22:13Z","timestamp":1774437733170,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":277,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002967","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:38:44Z","timestamp":1069385924000},"source":"Crossref","is-referenced-by-count":63,"title":["Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus"],"prefix":"10.1002","author":[{"given":"S","family":"Salpeter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Greyber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Salpeter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"key":"10.1002\/14651858.CD002967-BIB1|cit1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2796.1998.00361.x","article-title":"Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment","volume":"244","author":"Aarsand","year":"1998","journal-title":"Journal of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2337\/diacare.20.12.1863","article-title":"Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue","volume":"20","author":"Abbasi","year":"1997","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2337\/diacare.21.8.1301","article-title":"Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin [see comments]","volume":"21","author":"Abbasi","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB4|cit4","unstructured":"Abbink A (no title)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB5|cit5","first-page":"A39","article-title":"Vascular effects of glibenclamide, glimepiride, metformin and acarbose in Type 2 DM patients","volume":"43","author":"Abbink","year":"2000","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB6|cit6","first-page":"71","article-title":"Combination daytime chlorpropamide-metformin\/bedtime insulin in the treatment of secondary failures in non insulin dependent diabetes","volume":"44","author":"Aguilar","year":"1992","journal-title":"Revista de Investigacion Clinica"},{"key":"10.1002\/14651858.CD002967-BIB7|cit7","first-page":"347","article-title":"[Dimethylbiguanide in the treatment of diabetes mellitus]","volume":"2","author":"Allen","year":"1961","journal-title":"La Revue Francaise d'Endocrinologie Clinique"},{"key":"10.1002\/14651858.CD002967-BIB8|cit8","first-page":"1029","article-title":"[Experience with biguanide treatment for diabetes mellitus]","volume":"103","author":"Andras","year":"1962","journal-title":"Orvosi hetilap"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB9|cit9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.7326\/0003-4819-131-3-199908030-00004","article-title":"Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial","volume":"131","author":"Aviles-Santa","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB10|cit10","first-page":"1555","article-title":"[Treatment of diabetes with NN-Dimethyl Biguanide]","volume":"1","author":"Azerad","year":"1960","journal-title":"Gazette Medicale de France"},{"key":"10.1002\/14651858.CD002967-BIB11|cit11","first-page":"2770","article-title":"[N.N. dimethyl-biguanide (DMGG) in the treatment of Diabetes meliitus]","volume":"52","author":"Bacci","year":"1961","journal-title":"Minerva Medica"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB12|cit12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/diacare.19.3.252","article-title":"A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients","volume":"19","author":"Bayraktar","year":"1996","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB13|cit13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diabetes.48.1.198","article-title":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes","volume":"48","author":"Beisswenger","year":"1999","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD002967-BIB14|cit14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4158\/EP.3.2.73","article-title":"Outcome of metformin-facilitated reinitiation of oral diabetic therapy in insulin-treated patients with non-insulin-dependent diabetes mellitus","volume":"3","author":"Bell","year":"1997","journal-title":"Endocrinology Practice"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB15|cit15","first-page":"1426","article-title":"[Results in the treatment of diabetes with glucophage retard]","volume":"114","author":"Beyer","year":"1975","journal-title":"Therapie der Gegenwert"},{"key":"10.1002\/14651858.CD002967-BIB16|cit16","first-page":"567","article-title":"Metformin combined with chlorpropamide in the treatment of Diabetes mellitus","volume":"192","author":"Bingle","year":"1964","journal-title":"Practitioner"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB17|cit17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00422252","article-title":"Influence of phenformin and metformin on exercise induced lactataemia in patients with diabetes mellitus","volume":"15","author":"Bjorntorp","year":"1978","journal-title":"Diabetologia"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB18|cit18","first-page":"74","article-title":"[Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment]","volume":"200","author":"Boronat","year":"2000","journal-title":"Revista Clinica Espanola"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB19|cit19","first-page":"301","article-title":"Association of lactic acidosis with biguanide therapy [letter]","volume":"52","author":"Botha","year":"1977","journal-title":"South African Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB20|cit20","first-page":"69","article-title":"Insulin, glibenclamide or metformin treatment for non insulin dependent diabetes: heterogenous responses of standard measures of insulin action and insulin secretion before and after differing hypoglycaemic therapy","volume":"19","author":"Boyd","year":"1992","journal-title":"Diabetes Research"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/S0149-2918(99)80047-2","article-title":"Metformin as secondary therapy in a defined population with Type 2 Diabetes","volume":"21","author":"Brown","year":"1999","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB22|cit22","first-page":"183","article-title":"A comparison of phenformin and metformin in the treatment of maturity onset diabetes","volume":"3","author":"Cairns","year":"1977","journal-title":"Diabete & Metabolisme"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB23|cit23","first-page":"256","article-title":"Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment","volume":"21","author":"Calle-Pascual","year":"1995","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB24|cit24","first-page":"613","article-title":"Effects of metformin on blood pressure and microalbuminuria in diabetes mellitus","volume":"14","author":"Campbell","year":"1988","journal-title":"Diabete & Metabolisme"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB25|cit25","first-page":"394","article-title":"One year comparative trial of metformin and glipizide in type 2 diabetes mellitus","volume":"20","author":"Campbell","year":"1994","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB26|cit26","first-page":"2038","article-title":"[The treatment of Diabetes mellitus: Statistical results after a review of 1190 cases]","volume":"70","author":"Canivet","year":"1962","journal-title":"La Presse Medicale"},{"key":"10.1002\/14651858.CD002967-BIB27|cit27","first-page":"23","article-title":"Influence of metformin on arginine-induced glucagon secretion in human diabetes","volume":"1","author":"Carpentier","year":"1975","journal-title":"Diabete & Metabolisme"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB28|cit28","first-page":"45","article-title":"The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment","volume":"11","author":"Cavallo-Perin","year":"1989","journal-title":"European Review for Medical Pharmacological Science"},{"key":"10.1002\/14651858.CD002967-BIB29|cit29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(65)92383-4","article-title":"Fibrinolyitic effect of metformin in coronary-artety disease","volume":"2","author":"Chakrabarti","year":"1965","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2337\/diacare.16.7.1035","article-title":"Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients","volume":"16","author":"Chan","year":"1993","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB31|cit31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.7326\/0003-4819-121-12-199412150-00004","article-title":"The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial [see comments]","volume":"121","author":"Chiasson","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB32|cit32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/sj.ijo.0800468","article-title":"Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes","volume":"21","author":"Wolever","year":"1997","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1002\/14651858.CD002967-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diacare.21.10.1612","article-title":"No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate [see comments]","volume":"21","author":"Wolever","year":"1998","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB34|cit34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diacare.24.6.989","article-title":"The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes","volume":"24","author":"Chiasson","year":"2001","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB35|cit35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.1992.7.2.81","article-title":"Plasma t-PA and PAl-1 antigen concentrations in non-insulin dependent diabetic patients: effects of treatment modality on fibrinolysis","volume":"7","author":"Cho","year":"1992","journal-title":"Korean Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD002967-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0140-6736(65)91893-3","article-title":"Combined Metformin-Chlorpropamide therapy in 108 diabetic sulphonylurea-failures","volume":"1","author":"Clarke","year":"1965","journal-title":"Lancet"},{"issue":"7534","key":"10.1002\/14651858.CD002967-BIB37|cit37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(68)92726-8","article-title":"Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics","volume":"1","author":"Clarke","year":"1968","journal-title":"Lancet"},{"issue":"6102","key":"10.1002\/14651858.CD002967-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/bmj.2.6102.1576","article-title":"Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet","volume":"2","author":"Clarke","year":"1977","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB39|cit39","first-page":"420","article-title":"Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients","volume":"15","author":"Collier","year":"1989","journal-title":"Diabete & Metabolism"},{"key":"10.1002\/14651858.CD002967-BIB40|cit40","first-page":"4059","article-title":"Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus","volume":"81","author":"Cusi","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB41|cit41","first-page":"101","article-title":"[Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months]","volume":"21","author":"D'Argenzio","year":"1996","journal-title":"Minerva Endocrinologica"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2337\/diacare.21.9.1489","article-title":"Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin","volume":"21","author":"Damsbo","year":"1998","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB43|cit43","first-page":"A184","article-title":"Effect of metformin\/glyburide tablets on HBA1c in first-line treatment of Type 2 Diabetes","volume":"43","author":"Davidson","year":"2000","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD002967-BIB44|cit44","first-page":"223","article-title":"Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment","volume":"5","author":"Silva","year":"1979","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-73-6-1294","article-title":"Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects","volume":"73","author":"DeFronzo","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB46|cit46","first-page":"146A (abs 455)","article-title":"Combined metformin\/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonyluria: Results of a multicenter trial","volume":"42","year":"1993","journal-title":"Diabetes"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB47|cit47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group [see comments]","volume":"333","author":"DeFronzo","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB48|cit48","first-page":"Abs 178","article-title":"Efficacy and safety of metformin in NIDDM: Results of a muticenter trial","volume":"42","year":"1993","journal-title":"Diabetes"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB49|cit49","first-page":"131","article-title":"[Long range results (5 years) in the treatment of stable diabetes with low doses of clorpropamide-metformin (author's transl)]","volume":"30","author":"Dies","year":"1978","journal-title":"La Revista de Inverstigation Clinica"},{"key":"10.1002\/14651858.CD002967-BIB50|cit50","first-page":"142","article-title":"Dimethyldiguanide in diabetes mellitus: Report of a small trial","volume":"47","author":"Donnelly","year":"1960","journal-title":"Journal of the Irish Medical Association"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD002967-BIB51|cit51","first-page":"5 (Abs A17)","article-title":"Metformin monotherapy for obese non-insulin-dependent diabetes. A double-blind evaluation","volume":"5","author":"Dornan","year":"1988","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB52|cit52","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2337\/diacare.14.4.342","article-title":"Double-blind evaluation of efficacy and tolerability of metformin in NIDDM","volume":"14","author":"Dornan","year":"1991","journal-title":"Diabetes Care"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB53|cit53","first-page":"197","article-title":"The effects of oral hypoglycaemic drugs on serum lipids and lipoproteins in non-insulin-dependent diabetes (NIDDM)","volume":"17","author":"Elkeles","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"1-2","key":"10.1002\/14651858.CD002967-BIB54|cit54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s005920050146","article-title":"A comparison of preconstituted, fixed combinations of low-dose glyburide plus metformin versus high-dose glyburide alone in the treatment of type 2 diabetic patients","volume":"36","author":"Erle","year":"1999","journal-title":"Acta Diabetologia"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/diacare.19.11.1185","article-title":"Metformin's effects on glucose and lipid metabolism in patients with secondary failure to sulfonylureas","volume":"19","author":"Fanghanel","year":"1996","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB56|cit56","first-page":"389","article-title":"Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes","volume":"50","author":"Fanghanel","year":"1998","journal-title":"La Revista de Investigacion Clinica"},{"issue":"250","key":"10.1002\/14651858.CD002967-BIB57|cit57","first-page":"137","article-title":"Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes","volume":"66","author":"Ferner","year":"1988","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB58|cit58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000006909","article-title":"Antihyperglycemic treatment in diabetics with coronary disease: Increased metformin-associated mortality over a 5-year follow-up","volume":"91","author":"Fisman","year":"1999","journal-title":"Cardiology"},{"key":"10.1002\/14651858.CD002967-BIB59|cit59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/clc.4960240210","article-title":"Oral antidiabetic treatment in patients with coronary disease: Time-related increased mortality on combined glyburide\/metformin therapy over a 7.7-year follow-up","volume":"24","author":"Fisman","year":"2001","journal-title":"Clinical Cardiology"},{"issue":"13","key":"10.1002\/14651858.CD002967-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.283.13.1695","article-title":"Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"283","author":"Fonseca","year":"2000","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB61|cit61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s005920070030","article-title":"Intensive insulin therapy combined with metformin in obese type 2 diabetic patients","volume":"37","author":"Fritsche","year":"2000","journal-title":"Acta Diabetologia"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB62|cit62","first-page":"71","article-title":"[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data]","volume":"23","author":"Galeone","year":"1998","journal-title":"Minerva Endocrinologica"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB63|cit63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","article-title":"Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial","volume":"103","author":"Garber","year":"1997","journal-title":"American Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB64|cit64","first-page":"347","article-title":"[Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results]","volume":"36","author":"Garcia","year":"1971","journal-title":"La Prensa Medica Mexicana"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB65|cit65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00315466","article-title":"Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors","volume":"44","author":"Giugliano","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD002967-BIB66|cit66","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/bmj.1.5279.680","article-title":"Metformin in treatment of Diabetes mellitus","volume":"5279","author":"Gottlieb","year":"1962","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB67|cit67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1464-5491.1991.tb01610.x","article-title":"Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients","volume":"8","author":"Grant","year":"1991","journal-title":"Diabetic Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB68|cit68","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diacare.19.1.64","article-title":"The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes","volume":"19","author":"Grant","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB69|cit69","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0037-1615172","article-title":"Metformin reduces circulating Factor VII concentrations in patients with Type II Diabetes mellitus","volume":"80","author":"Grant","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB70|cit70","first-page":"200","article-title":"[Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus]","volume":"9","author":"Gregorio","year":"1989","journal-title":"Medicina (Firenze)"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB71|cit71","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02581286","article-title":"Low dose metformin in the treatment of type II non-insulin-dependent diabetes: clinical and metabolic evaluations","volume":"27","author":"Gregorio","year":"1990","journal-title":"Acta Diabetologica Latina"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB72|cit72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0168-8227(97)00047-8","article-title":"Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study","volume":"37","author":"Gregorio","year":"1997","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB73|cit73","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00285334","article-title":"Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus","volume":"32","author":"Groop","year":"1989","journal-title":"Diabetologia"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB74|cit74","first-page":"218","article-title":"Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?","volume":"17","author":"Groop","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB75|cit75","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/(SICI)1096-9136(199709)14:9<798::AID-DIA420>3.0.CO;2-C","article-title":"Monitoring of metabolic control in patients with non-insulin-dependent diabetes mellitus on oral hypoglycaemic agents: value of evening blood glucose determination","volume":"14","author":"Guillausseau","year":"1997","journal-title":"Diabete & Metabolisme"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB76|cit76","first-page":"A150","article-title":"The effect of metformin on insulin resistance and serum lipid profiles","volume":"43","author":"Gursoy","year":"2000","journal-title":"Diabetologia"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB77|cit77","first-page":"224","article-title":"Oral antidiabetic combination therapy with sulphonylureas and metformin","volume":"17","author":"Haupt","year":"1991","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB78|cit78","first-page":"286","article-title":"Dimethyldiguanide (Glucophage, LA 6023) in Diabetes mellitus","volume":"35","author":"Herman","year":"1961","journal-title":"South African Medical Journal"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB79|cit79","first-page":"201","article-title":"Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus","volume":"17","author":"Hermann","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB80|cit80","first-page":"174","article-title":"Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus","volume":"17","author":"Hermann","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB81|cit81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00315441","article-title":"Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles","volume":"41","author":"Hermann","year":"1991","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB82|cit82","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1464-5491.1994.tb00253.x","article-title":"Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination","volume":"11","author":"Hermann","year":"1994","journal-title":"Diabete & Metabolisme"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diacare.17.10.1100","article-title":"Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study [see comments]","volume":"17","author":"Hermann","year":"1994","journal-title":"Diabetes Care"},{"issue":"154-6","key":"10.1002\/14651858.CD002967-BIB84|cit84","article-title":"Double-blind trial of metformin in the therapy of non-ketotic diabetics","volume":"2","author":"Higginbotham","year":"1979","journal-title":"Medical Journal of Australia"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB85|cit85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2337\/diacare.22.5.854b","article-title":"Metformin added to insulin therapy in poorly controlled Type-II Diabetes","volume":"22","author":"Hirsch","year":"1999","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB86|cit86","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9343(97)00252-0","article-title":"Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study","volume":"103","author":"Hoffmann","year":"1997","journal-title":"American Journal of Medicien"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB87|cit87","first-page":"483","article-title":"Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria","volume":"17","author":"Hollenbeck","year":"1991","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB88|cit88","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1464-5491.1987.tb00909.x","article-title":"Sulphonylurea failure in Type 2 Diabetes: Treatment with a basal insulin supplement","volume":"4","author":"Holman","year":"1987","journal-title":"Diabete & Metabolisme"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB89|cit89","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/diacare.23.11.1660","article-title":"Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes","volume":"23","author":"Horton","year":"2000","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB90|cit90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/acta.0.1200257","article-title":"Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes","volume":"120","author":"Hother-Nielsen","year":"1989","journal-title":"Acta Endocrinologica (Copenhagen)"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB91|cit91","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2337\/diacare.21.12.2135","article-title":"Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy","volume":"21","author":"Imano","year":"1998","journal-title":"Diabetes Care"},{"issue":"13","key":"10.1002\/14651858.CD002967-BIB92|cit92","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus [see comments]","volume":"338","author":"Inzucchi","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB93|cit93","first-page":"727","article-title":"Combined oral therapy in Diabetes","volume":"36","author":"Jackson","year":"1962","journal-title":"South African Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB94|cit94","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diab.36.5.632","article-title":"Mechanism of metformin action in non-insulin-dependent diabetes","volume":"36","author":"Jackson","year":"1987","journal-title":"Diabetes"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2337\/diacare.17.10.1093","article-title":"Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM","volume":"17","author":"Jeppesen","year":"1994","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB96|cit96","first-page":"219","article-title":"Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin","volume":"10","author":"Johansen","year":"1984","journal-title":"Diabete & Metabolisme"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0026-0495(93)90284-U","article-title":"The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients","volume":"42","author":"Johnson","year":"1993","journal-title":"Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB98|cit98","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0149-2918(98)80132-X","article-title":"A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes","volume":"20","author":"Johnson","year":"1998","journal-title":"Clinical Therapeutics"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB99|cit99","first-page":"A192","article-title":"Long-term efficacy of rosiglitazone as monotherapy or in combination with metformin","volume":"43","author":"Jones","year":"2000","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB100|cit100","first-page":"A191","article-title":"Addition of rosiglitazone to metformin is effective in obese, insulin-resistant patients with Type 2 Diabetes","volume":"43","author":"Jones","year":"2000","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB101|cit101","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1464-5491.1990.tb01433.x","article-title":"Comparison of tolbutamide and metformin in elderly diabetic patients","volume":"7","author":"Josephkutty","year":"1990","journal-title":"Diabete & Metabolisme"},{"issue":"Suppl","key":"10.1002\/14651858.CD002967-BIB102|cit102","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/0168-8227(95)01081-N","article-title":"Acarbose for the treatment of type II diabetes: the results of a Canadian multi-centre trial [published erratum appears in Diabetes Res Clin Pract 1995 Sep;29(3):215]","volume":"28","author":"Josse","year":"1995","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB103|cit103","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diacare.22.5.859b","article-title":"Metformin and Lipoprotein (a) levels","volume":"22","author":"Kiayias","year":"1999","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB104|cit104","first-page":"879","article-title":"Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes?","volume":"48","author":"Kirk","year":"1999","journal-title":"Journal of Family Practice"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB105|cit105","first-page":"516","article-title":"[Therapy of diabetes mellitus using metformin. Clinical study on 60 patients]","volume":"26","author":"Klein","year":"1975","journal-title":"Medizinische Welt"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB106|cit106","first-page":"235","article-title":"Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients","volume":"17","author":"Klein","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB107|cit107","first-page":"329","article-title":"Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly)","volume":"28","author":"Lalau","year":"1990","journal-title":"International Journal Clinical Pharmacocology Therapeutics and Toxicology"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB108|cit108","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1464-5491.1990.tb01378.x","article-title":"Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients","volume":"7","author":"Lalor","year":"1990","journal-title":"Diabete & Metabolisme"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB109|cit109","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2337\/diacare.21.7.1154","article-title":"Acarbose in NIDDM patients with poor control on conventional oral agents","volume":"21","author":"Lam","year":"1998","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB110|cit110","first-page":"259","article-title":"[Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics]","volume":"140","author":"Laurenti","year":"1992","journal-title":"La Clinica Terapeutica"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB111|cit111","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00544012","article-title":"Ciclazindol: an oral agent with weight reducing properties and hypoglycaemic activity","volume":"25","author":"Lean","year":"1983","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB112|cit112","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","article-title":"Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes","volume":"6","author":"Lee","year":"1998","journal-title":"Obesity Research"},{"issue":"6368","key":"10.1002\/14651858.CD002967-BIB113|cit113","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bmj.286.6368.830","article-title":"Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes","volume":"286","author":"Lord","year":"1983","journal-title":"British Medical Journal (Clinical Research Edition)"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB114|cit114","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8227(96)01277-6","article-title":"Different effect of acute and chronic oral metformin administration on glucose and insulin response to bread and to pasta in non-insulin dependent diabetic patients","volume":"33","author":"Lunetta","year":"1996","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB115|cit115","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s001250051172","article-title":"Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus","volume":"42","author":"Makimattila","year":"1999","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB116|cit116","first-page":"15","article-title":"Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes [see comments]","volume":"20","author":"Marena","year":"1994","journal-title":"Diabete & Metabolisme"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB117|cit117","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.19.9.934","article-title":"Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients","volume":"19","author":"Marfella","year":"1996","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB118|cit118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00614548","article-title":"A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes","volume":"34","author":"McAlpine","year":"1988","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB119|cit119","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.41.9.933","article-title":"Effects of improved glycaemic control on calcium and magnesium homeostasis in type II diabetes","volume":"41","author":"McBain","year":"1988","journal-title":"Journal of Clinical Pathology"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB120|cit120","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1445-5994.1991.tb01375.x","article-title":"Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus","volume":"21","author":"McIntyre","year":"1991","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB121|cit121","first-page":"151","article-title":"Utility of Metformin as a non-hormonal agent in the treatment of Diabetes mellitus","volume":"40","author":"Mehta","year":"1963","journal-title":"Journal of the Indian Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB122|cit122","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1185\/03007998909115209","article-title":"Metformin efficacy and tolerance in obese non-insulin dependent diabetics: a comparison of two dosage schedules","volume":"11","author":"Menzies","year":"1989","journal-title":"Current Medical Research and Opinion"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD002967-BIB123|cit123","first-page":"S136","article-title":"Repaglinide in combination therapy with metformin in Type 2 diabetes","volume":"107","author":"Moses","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB124|cit124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/diacare.22.1.119","article-title":"Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes","volume":"22","author":"Moses","year":"1999","journal-title":"Diabetes Care"},{"issue":"14","key":"10.1002\/14651858.CD002967-BIB125|cit125","first-page":"681","article-title":"[Treatment of obese diabetic patients using glucophage retard]","volume":"51","author":"Munk","year":"1975","journal-title":"Zeltschrift fur Allgemeinmedzin"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB126|cit126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/(SICI)1096-9136(199608)13:8<753::AID-DIA163>3.0.CO;2-Z","article-title":"Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus","volume":"13","author":"Nagi","year":"1996","journal-title":"Diabete & Metabolisme"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB127|cit127","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diacare.16.4.621","article-title":"Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups [see comments]","volume":"16","author":"Nagi","year":"1993","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB128|cit128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00745143","article-title":"Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics","volume":"13","author":"Nattrass","year":"1977","journal-title":"Diabetologia"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB129|cit129","first-page":"336","article-title":"Comparison of bedtime NPH insulin or metformin combined with glibenclamide in secondary sulphonylurea failure in obese type II (NIDDM) patients","volume":"48","author":"Niazi","year":"1998","journal-title":"Journal of the Pakistani Medical Association"},{"key":"10.1002\/14651858.CD002967-BIB130|cit130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2337\/diacare.10.1.62","article-title":"Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in Type 2 diabetes","volume":"10","author":"Nosadini","year":"1987","journal-title":"Diabetes Care"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB131|cit131","first-page":"209","article-title":"Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD","volume":"17","author":"Noury","year":"1991","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB132|cit132","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF01537460","article-title":"The influence of Dimethylbiguanide on Phenprocoumon elimination and its mode of action","volume":"61","author":"Ohnhaus","year":"1983","journal-title":"Klinische Wochenschrift"},{"issue":"6435","key":"10.1002\/14651858.CD002967-BIB133|cit133","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1136\/bmj.288.6435.1956","article-title":"The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?","volume":"288","author":"Peacock","year":"1984","journal-title":"British Medicial Journal (Clinical Research Edition)"},{"key":"10.1002\/14651858.CD002967-BIB134|cit134","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-0038-1661564","article-title":"Platelet behaviour in non-insulin-dependent Diabetes - Influence of vascular complications, treatment and metabolic control","volume":"55","author":"Peacock","year":"1986","journal-title":"Thrombosis and heamostasis"},{"key":"10.1002\/14651858.CD002967-BIB135|cit135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/acta.0.0490479","article-title":"The effect of Metformin on weight loss in obesity","volume":"49","author":"Pedersen","year":"1965","journal-title":"Acta Endocrinologica"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB136|cit136","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1464-5491.1989.tb01156.x","article-title":"The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes","volume":"6","author":"Pedersen","year":"1989","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB137|cit137","first-page":"575","article-title":"[A new oral antidiabetic medicine: N.N. Dimethylbiguanide. Clinical trial alternating a placebo with a sulfamide]","volume":"16","author":"Pirart","year":"1961","journal-title":"Acta Clinica Belgica"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB138|cit138","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0149-2918(00)90005-5","article-title":"Combined metformin and insulin therapy for patients with type 2 diabetes mellitus [In Process Citation]","volume":"22","author":"Ponssen","year":"2000","journal-title":"Clinical Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB139|cit139","first-page":"346","article-title":"Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus","volume":"12","author":"Prager","year":"1986","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB140|cit140","first-page":"335","article-title":"[Experience with the biguanide Glucophage]","volume":"76","author":"Puchegger","year":"1964","journal-title":"Wiener Klinische Wechenschrift"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB141|cit141","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1464-5491.1988.tb01074.x","article-title":"The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes","volume":"5","author":"Rains","year":"1988","journal-title":"Diabete & Metabolisme"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB142|cit142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/014107688908200213","article-title":"The reduction of low density lipoprotein cholesterol by metformin is maintained with long-term therapy","volume":"82","author":"Rains","year":"1989","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB143|cit143","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-2007-979135","article-title":"Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients","volume":"28","author":"Raptis","year":"1996","journal-title":"Hormone and Metabolic Research"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB144|cit144","first-page":"1020","article-title":"Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control","volume":"74","author":"Reaven","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB145|cit145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/(SICI)1096-9136(1998120)15:12<997::AID-DIA716>3.0.CO;2-B","article-title":"Adding metformin versus insulin dose increase in insulin-treated but poorly controlled Type 2 diabetes mellitus: an open-label randomized trial","volume":"15","author":"Relimpio","year":"1998","journal-title":"Diabete & Metabolisme"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB146|cit146","first-page":"378","article-title":"[Chlorpropamide-dimethylbiguanide combination in the control of diabetes mellitus with complications]","volume":"34","author":"Reyes","year":"1969","journal-title":"La Prensa Medica Mexicana"},{"issue":"1 pt 2","key":"10.1002\/14651858.CD002967-BIB147|cit147","first-page":"180","article-title":"Glucose and lipid metabolism in non-insulin-dependent diabetes, effect of metformin","volume":"17","author":"Riccio","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB148|cit148","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diacare.21.5.701","article-title":"The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control [see comments]","volume":"21","author":"Robinson","year":"1998","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB149|cit149","first-page":"318","article-title":"Clinical experience with acarbose: results of a Canadian multicentre study","volume":"18","author":"Rodger","year":"1995","journal-title":"Clinical Investigation in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB150|cit150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1056-8727(98)00004-X","article-title":"Addition of benflouorex to biguanide improves glycemic control in obese non-insulin-dependent diabets: a double-blind study versus placebo","volume":"13","author":"Roger","year":"1999","journal-title":"Journal of Diabetes and its complications"},{"key":"10.1002\/14651858.CD002967-BIB151|cit151","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2337\/diacare.21.12.2050","article-title":"Efficacy and safety of Acarbose in Metformin-treated patients with Type 2 Diabetes","volume":"21","author":"Rosenstock","year":"1998","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB152|cit152","first-page":"462","article-title":"[The combination of insulin and metformin in obese patients with type-2 diabetes mellitus]","volume":"24","author":"Sanchez-Barba","year":"1999","journal-title":"Atencion Primaria"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB153|cit153","first-page":"274","article-title":"Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes","volume":"21","author":"Santos","year":"1995","journal-title":"Diabete & Metabolisme"},{"issue":"1-2","key":"10.1002\/14651858.CD002967-BIB154|cit154","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0021-9150(90)90148-C","article-title":"Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus","volume":"82","author":"Schneider","year":"1990","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB155|cit155","first-page":"281","article-title":"[Long-term (3 year) results of the treatment of stable diabetes with low doses of chlopropamide-metformin]","volume":"38","author":"Schulte","year":"1973","journal-title":"La Prensa Medica Mexicana"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB156|cit156","first-page":"335","article-title":"[Assessment of efficacy and safety of acarbose in the treatment of diabetes mellitus. Observation study in the conditions of general health care]","volume":"56","author":"Siedradzki","year":"1999","journal-title":"Przeglad Lekarski"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB157|cit157","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0300-2977(99)00128-X","article-title":"Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study","volume":"56","author":"Stades","year":"2000","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB158|cit158","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2337\/diacare.14.1.12","article-title":"Metabolic control in diabetic subjects in three Swedish areas with high, medium and low sales of antidiabetic drugs","volume":"14","author":"Stalhammer","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB159|cit159","first-page":"599","article-title":"[Report on five years experience with Metformin]","volume":"113","author":"Sterne","year":"1963","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD002967-BIB160|cit160","first-page":"2743","article-title":"[Experience with Dimethylbiguanide in late failrues of oral diabetes therapy]","volume":"49","author":"Stratmann","year":"1965","journal-title":"Medizinische Welt"},{"key":"10.1002\/14651858.CD002967-BIB161|cit161","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM199508313330903","article-title":"Metabolic effects of metformin in non-insulin-dependent diabetes mellitus","volume":"333","author":"Stumvoll","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB162|cit162","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2337\/diacare.20.5.692","article-title":"Comparative effects of glibenclamide and metformin on ambulatory blood pressure and cardiovascular reactivity in NIDDM","volume":"20","author":"Sundaresan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB163|cit163","first-page":"62","article-title":"Safety and efficacy of metformin in a restricted formulary","volume":"5","author":"Swislocki","year":"1999","journal-title":"American Journal of Managed Care"},{"key":"10.1002\/14651858.CD002967-BIB164|cit164","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02953855","article-title":"Combined trial of Acetohexamide and two Diguanide preparations","author":"Szanto","year":"1964","journal-title":"Irish Journal of Medical Science"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB165|cit165","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF00254300","article-title":"A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes","volume":"23","author":"Taylor","year":"1982","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB166|cit166","first-page":"1553","article-title":"Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes","volume":"79","author":"Tessari","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"7","key":"10.1002\/14651858.CD002967-BIB167|cit167","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0026-0495(99)90226-3","article-title":"Effects of gliclazide versus metformin on the clinical profile and lipid peroxidation markers in type 2 diabetes","volume":"48","author":"Tessier","year":"1999","journal-title":"Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB168|cit168","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0168-8227(96)01286-7","article-title":"Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitus","volume":"33","author":"Testa","year":"1996","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB169|cit169","first-page":"213","article-title":"Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes","volume":"17","author":"Teupe","year":"1991","journal-title":"Diabete & Metabolisme"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB170|cit170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diacare.15.4.539","article-title":"Comparison of combined therapies in treatment of secondary failure to glyburide","volume":"15","author":"Trischitta","year":"1992","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB171|cit171","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF03348039","article-title":"Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?","volume":"21","author":"Trischitta","year":"1998","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD002967-BIB172|cit172","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diacare.22.6.960","article-title":"A randomized double-blind trial of Acarbose in Type II Diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44)","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB173|cit173","first-page":"136","article-title":"United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus","volume":"124","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"21","key":"10.1002\/14651858.CD002967-BIB174|cit174","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group","volume":"281","year":"1999","journal-title":"Journal of the American Medical Association"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB175|cit175","first-page":"1249","article-title":"U. K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group [published erratum appears in Diabetes 1996 Nov;45(11):1655]","volume":"44","year":"1995","journal-title":"Diabetes"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB176|cit176","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/diab.34.8.793","article-title":"U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study","volume":"34","year":"1985","journal-title":"Diabetes"},{"issue":"6972","key":"10.1002\/14651858.CD002967-BIB177|cit177","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.310.6972.83","article-title":"United Kingdom Prospective Diabetes Study (UKPDS) 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years [see comments]","volume":"310","year":"1995","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB178|cit178","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-128-3-199802010-00001","article-title":"United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy [see comments]","volume":"128","year":"1998","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB179|cit179","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2337\/diacare.21.1.87","article-title":"UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes","volume":"21","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB180|cit180","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB181|cit181","first-page":"578","article-title":"Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus","volume":"78","author":"Vannasaeng","year":"1995","journal-title":"Journal of the Medical Association of Thailand"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB182|cit182","first-page":"483","article-title":"[Median-term (4 months) treatment with glibenclamide + metformin substituting for glibenclamide + fenformin lowers the lacticemia levels in type-2 diabetics (NIDDM)]","volume":"141","author":"Velussi","year":"1992","journal-title":"La Clinical Terapeutica"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD002967-BIB183|cit183","first-page":"232","article-title":"Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide","volume":"17","author":"Vigneri","year":"1991","journal-title":"Diabete & Metabolisme"},{"key":"10.1002\/14651858.CD002967-BIB184|cit184","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1464-5491.1992.tb01793.x","article-title":"The effects of dexfenluramine on blood glucose control in patients with Type 2 Diabetes","volume":"9","author":"Willey","year":"1992","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD002967-BIB185|cit185","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-5491.1994.tb00336.x","article-title":"Obese patients with type 2 Diabetes poorly controlled by insulin and metformin: Effects of adjunctive Dexfenfluramine therapy on glycaemic control","volume":"11","author":"Willey","year":"1994","journal-title":"Diabetic Medicine"},{"issue":"9","key":"10.1002\/14651858.CD002967-BIB186|cit186","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1464-5491.1999.00149.x","article-title":"Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study","volume":"16","author":"Willms","year":"1999","journal-title":"Diabetic Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB187|cit187","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2007-1009224","article-title":"A comparison of metformin versus guar in combination with sulphonylureas in the treatment of non insulin dependent diabetes","volume":"21","author":"Wilson","year":"1989","journal-title":"Hormone and Metabolic Research"},{"key":"10.1002\/14651858.CD002967-BIB188|cit188","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1464-5491.1995.tb00448.x","article-title":"One-year Acarbose treatment raises fasting serum acetate in Diabetic patients","volume":"12","author":"Wolever","year":"1995","journal-title":"Diabetic Medicine"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB189|cit189","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0271-5317(00)80025-1","article-title":"Miglitol, an alpha-glucosidase inhibitor, prevents the metformin-induced fall in serum folate and vitamin B12 in subjects with type 2 diabetes","volume":"20","author":"Wolever","year":"2000","journal-title":"Nutrition Research"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB190|cit190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diacare.13.1.1","article-title":"Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients","volume":"13","author":"Wu","year":"1990","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB191|cit191","first-page":"A184","article-title":"Metformin and insulin therapy decreases glycosylated hemoglobin and insulin requirement in Type 2 Diabetes","volume":"43","author":"Wulffele","year":"2000","journal-title":"Diabetologia"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB192|cit192","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-130-5-199903020-00002","article-title":"Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial [see comments]","volume":"130","author":"Yki-Jarvinen","year":"1999","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB193|cit193","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2337\/diabetes.48.12.2414","article-title":"A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients","volume":"48","author":"Yu","year":"1999","journal-title":"Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB194|cit194","first-page":"19","article-title":"Biguanide related lactic acidosis: incidence and risk factors","volume":"23","author":"Aguilar","year":"1992","journal-title":"Archives of Medical Research"},{"issue":"14","key":"10.1002\/14651858.CD002967-BIB195|cit195","first-page":"2763","article-title":"[Tolbutamide-dimethyl-biguanide association in the treatment of diabetes mellitus]","volume":"72","author":"Bernard","year":"1965","journal-title":"Gazette Medicale de France"},{"key":"10.1002\/14651858.CD002967-BIB196|cit196","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00007691-199906000-00015","article-title":"Determination of plasma Metformin by a new cation-exchange HPLC technique","volume":"21","author":"Bonfigli","year":"1999","journal-title":"Therapeutic Drug Monitoring"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB197|cit197","first-page":"88","article-title":"[Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics]","volume":"5","author":"Bruneder","year":"1978","journal-title":"Acta Medica Austriaca"},{"key":"10.1002\/14651858.CD002967-BIB198|cit198","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-9149(91)90617-T","article-title":"Effectiveness of Glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent Diabetes mellitus","volume":"67","author":"Cacciapuoti","year":"1991","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB199|cit199","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2337\/diacare.18.3.307","article-title":"Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients","volume":"18","author":"Chow","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB200|cit200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/(SICI)1096-9136(199605)13:5<471::AID-DIA103>3.0.CO;2-T","article-title":"Saytime Glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary Sulphonylurea failure: a 1-year follow-up","volume":"13","author":"Clauson","year":"1995","journal-title":"Diabetic Medicine"},{"issue":"848","key":"10.1002\/14651858.CD002967-BIB201|cit201","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/pgmj.72.848.352","article-title":"Metformin treatment in NIDDM patients with mild renal impairment","volume":"72","author":"Connolly","year":"1996","journal-title":"Postgraduate Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB202|cit202","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/106002809703100414","article-title":"Metformin and insulin: is there a role for combination therapy?","volume":"31","author":"Daniel","year":"1997","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD002967-BIB203|cit203","first-page":"239","article-title":"[Study of lactic acid levels on an empty stomach in diabetic patients treated with N-N-dimethylbiguanide]","volume":"12","author":"Debry","year":"1964","journal-title":"Diabete"},{"key":"10.1002\/14651858.CD002967-BIB204|cit204","first-page":"407","article-title":"[Results of the treatment of Diabetes mellitus in the adult with the association of Metformin and sulfamides (concerning 197 cases)]","volume":"47","author":"Debry","year":"1966","journal-title":"Journal de Medicine de Lyon"},{"key":"10.1002\/14651858.CD002967-BIB205|cit205","first-page":"395","article-title":"[Results of the treatment of Diabetes mellitus in the adult with metformin (concerning 202 cases0]","volume":"47","author":"Debry","year":"1966","journal-title":"Journal de Medicine de Lyon"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB206|cit206","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0026-0495(97)90307-3","article-title":"Effects of metformin on the pathways of glucose utilization after oral glucose in non-insulin-dependent diabetes mellitus patients","volume":"46","author":"Fery","year":"1997","journal-title":"Metabolism"},{"key":"10.1002\/14651858.CD002967-BIB207|cit207","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/BF00404340","article-title":"Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM","volume":"37","author":"Galuska","year":"1994","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD002967-BIB208|cit208","first-page":"1369","article-title":"Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent Diabetes mellitus","volume":"80","author":"Gibson","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD002967-BIB209|cit209","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00257727","article-title":"Metformin reduces post-prandial insulin needs in Type 1 (Insulin-dependent) diabetic patients: Assessment by the artificial pancreas","volume":"23","author":"Gin","year":"1982","journal-title":"Diabetologia"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB210|cit210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0026-0495(85)90139-8","article-title":"Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients","volume":"34","author":"Gin","year":"1985","journal-title":"Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB211|cit211","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0168-8227(89)90058-2","article-title":"Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics","volume":"6","author":"Gin","year":"1989","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB212|cit212","first-page":"32","article-title":"Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes","volume":"34","author":"Giugliano","year":"1979","journal-title":"Farmaco edizione Pratica"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB213|cit213","first-page":"213","article-title":"Treatment of non-insulin-dependent diabetes mellitus with metformin","volume":"10","author":"Guthrie","year":"1997","journal-title":"Journal of the American Board of Family Practice"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB214|cit214","first-page":"332","article-title":"[The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)]","volume":"90","author":"Irsigler","year":"1978","journal-title":"Wiener Klinische Wochenschrift"},{"issue":"9-10","key":"10.1002\/14651858.CD002967-BIB215|cit215","first-page":"673","article-title":"The effect of metformin on individual amino acid absorption","volume":"61","author":"Ismail","year":"1978","journal-title":"Journal of the Egyptian Medical Association"},{"key":"10.1002\/14651858.CD002967-BIB216|cit216","first-page":"297","article-title":"[Glycemic equilibrium and weight evolution in diabetics taking metformin]","author":"Isnard","year":"1991","journal-title":"Journees Annuelles Diabetology Hotel-Dieu"},{"key":"10.1002\/14651858.CD002967-BIB217|cit217","first-page":"273","article-title":"[Long term treatment with biguanides in the natural evolution of non-insulin-dependent diabetes]","author":"Isnard","year":"1996","journal-title":"Journ Annu Diabetol Hotel Dieu"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB218|cit218","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2337\/diacare.19.2.160","article-title":"The effect of metformin on adipose tissue metabolism and peripheral blood flow in subjects with NIDDM","volume":"19","author":"Jansson","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB219|cit219","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2337\/diacare.22.1.33","article-title":"Efficacy of metformin in the treatment of NIDDM: Meta-analysis","volume":"22","author":"Johansen","year":"1999","journal-title":"Diabetes Care"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD002967-BIB220|cit220","first-page":"126","article-title":"Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis","volume":"9","author":"Lalau","year":"1994","journal-title":"Nephrology Dialysis and Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB221|cit221","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diacare.18.6.779","article-title":"Role of metformin accumulation in metformin-associated lactic acidosis","volume":"18","author":"Lalau","year":"1995","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB222|cit222","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1042\/cs0730041","article-title":"Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy","volume":"73","author":"Leslie","year":"1987","journal-title":"Clinical Science"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB223|cit223","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5694\/j.1326-5377.1970.tb77850.x","article-title":"Metformin compared with tolbutamide in the treatment of maturity-onset diabetes mellitus","volume":"1","author":"Lim","year":"1970","journal-title":"Medical Journal of Australia"},{"issue":"22","key":"10.1002\/14651858.CD002967-BIB224|cit224","first-page":"607","article-title":"[Treatment of 81 cases of diabetes mellitus with N.N. dimethyl-biguanide]","volume":"20","author":"Messens","year":"1965","journal-title":"Revue Medicale de Liege"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB225|cit225","first-page":"74","article-title":"[Treatment of diabetes mellitus with N.N. dimethy-biguanide]","volume":"14","author":"Messens","year":"1966","journal-title":"Diabete"},{"key":"10.1002\/14651858.CD002967-BIB226|cit226","first-page":"227","article-title":"[Dimethyl-biguanide in the treatment of diabetes mellitus]","volume":"35","author":"Muntoni","year":"1965","journal-title":"La Clinica terapeutica"},{"key":"10.1002\/14651858.CD002967-BIB227|cit227","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","article-title":"Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (17-36 amide) in Type 2 (non-insulin-dependent) diabetic patients","volume":"36","author":"Nauck","year":"1993","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD002967-BIB228|cit228","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-979067","article-title":"Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent Diabetes mellitus","volume":"29","author":"Nauck","year":"1997","journal-title":"Hormone and Metabolic Research"},{"issue":"5 Suppl","key":"10.1002\/14651858.CD002967-BIB229|cit229","first-page":"S13","article-title":"Care of adults with type 2 diabetes mellitus. A review of the evidence [see comments]","volume":"47","author":"O'Connor","year":"1998","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD002967-BIB230|cit230","first-page":"183","article-title":"[Influence of N.N. dimethyl biguandie on certain elements of lipid metabolism in diabetic patients]","volume":"14","author":"Orlikowska","year":"1966","journal-title":"Le Diabete"},{"issue":"37-42","key":"10.1002\/14651858.CD002967-BIB231|cit231","article-title":"Determinants of plasminogin activatory inhibitor 1 activiry in treated NIDDM and its relation to a polymorphosm in the Plasminogen Activator Inhibitor 1 gene","volume":"44","author":"Panahloo","year":"1995","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD002967-BIB232|cit232","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diab.43.7.920","article-title":"Acute antihyperglycemic mechanisms of Metformin in NIDDM: Evidence for suppression of lipid oxidation and hepatic glucose production","volume":"43","author":"Perriello","year":"1994","journal-title":"Diabetes"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB233|cit233","first-page":"91","article-title":"[Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing]","volume":"5","author":"Pilger","year":"1978","journal-title":"Acta Medica Austriaca"},{"issue":"12","key":"10.1002\/14651858.CD002967-BIB234|cit234","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diab.32.12.1083","article-title":"Insulin receptor binding to monocytes, insulin secretion, and glucose tolerance following metformin treatment. Results of a double-blind cross-over study in type II diabetics","volume":"32","author":"Prager","year":"1983","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD002967-BIB235|cit235","first-page":"247","article-title":"[Treatment of diabetes mellitus with NN-dimethyl-diguanide. Experience of 177 cases]","volume":"37","author":"Rambert","year":"1961","journal-title":"Semaine des Hospitaux de Paris"},{"issue":"622","key":"10.1002\/14651858.CD002967-BIB236|cit236","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/bmj.4.5622.25","article-title":"Circadian variation of glucose, insulin, and free fatty acids during long-term use of oral hypoglycaemic agents in diabetes mellitus","volume":"3","author":"Rigas","year":"1968","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB237|cit237","first-page":"219","article-title":"Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients","volume":"12","author":"Rizkalla","year":"1986","journal-title":"Diabete & Metabolisme"},{"issue":"11","key":"10.1002\/14651858.CD002967-BIB238|cit238","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/009127009603601105","article-title":"Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus","volume":"36","author":"Sambol","year":"1996","journal-title":"Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD002967-BIB239|cit239","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.0.CO;2-A","article-title":"Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus","volume":"15","author":"Scarpello","year":"1998","journal-title":"Diabetic Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB240|cit240","first-page":"269","article-title":"Metabolic effects of glucocorticoid and ethanol administration in phenformin- and metformin-treated obese diabetics","volume":"206","author":"Schaffalitzky","year":"1979","journal-title":"Acta Medica Scandinavia"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB241|cit241","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/diacare.22.1.38","article-title":"First 20 months' experience with use of metformin for type 2 diabetes in a large health maintenance organization","volume":"22","author":"Selby","year":"1999","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1002\/14651858.CD002967-BIB242|cit242","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-8227(96)01280-6","article-title":"The effect of metformin on liver blood flow in vivo in normal subjects and patients with non insulin dependent diabetes","volume":"33","author":"Signore","year":"1996","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.1002\/14651858.CD002967-BIB243|cit243","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(84)91045-6","article-title":"Sucrose taken during mixed meal has no additional hypergycemic action over isocaloric amounts of starch in well-controlled diabetics","volume":"July 21","author":"Slama","year":"1984","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD002967-BIB244|cit244","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<400::AID-DMRR66>3.0.CO;2-4","article-title":"Reversal of increased lymphocyte PC-1 activity in patients with type 2 diabetes treated with metformin","volume":"15","author":"Stefanovic","year":"1999","journal-title":"Diabetes\/Metabolism Research Reviews"},{"key":"10.1002\/14651858.CD002967-BIB245|cit245","first-page":"405","article-title":"[Clinical trial with DMBG (Melbin) in diabetes mellitus]","volume":"9","author":"Sugawara","year":"1962","journal-title":"Naika hokan, Japanese archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002967-BIB246|cit246","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1464-5491.1992.tb01716.x","article-title":"The effect of intravenous Metformin on glucose metabolism during hyperglycemia in Type 2 Diabetes","volume":"9","author":"Sum","year":"1992","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD002967-BIB247|cit247","first-page":"342","article-title":"[Biguanides and sulfamides in small doses in the initial treatment of diabetes in obese patients]","volume":"11","author":"Teitelbaum","year":"1963","journal-title":"Diabete"},{"issue":"4","key":"10.1002\/14651858.CD002967-BIB248|cit248","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/jcem-57-4-713","article-title":"Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients","volume":"57","author":"Trischitta","year":"1983","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"Suppl","key":"10.1002\/14651858.CD002967-BIB249|cit249","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/0168-8227(95)01105-M","article-title":"Lessons from IK prospective diabetes study","volume":"28","author":"Turner","year":"1995","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD002967-BIB250|cit250","first-page":"330","article-title":"Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent Diabetes mellitus (Type 2)","volume":"49","author":"Zapecka-Dubno","year":"1999","journal-title":"Arzliche-Forschung\/ Drug Research"},{"key":"10.1002\/14651858.CD002967-BIB251|cit251","first-page":"2755","article-title":"Metformin hydrochloride","volume-title":"American Hospital Formulary Service Drug Information","year":"1999"},{"key":"10.1002\/14651858.CD002967-BIB252|cit252","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB253|cit253","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bmj.2.6135.464","article-title":"Epidemiology of adverse drug reactions to phenformin and metformin","volume":"2","author":"Bergman","year":"1978","journal-title":"British Medicial Journal"},{"key":"10.1002\/14651858.CD002967-BIB254|cit254","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/sim.4780080202","article-title":"A comparison of statistical methods for combining event rates from clinical trials","volume":"8","author":"Berlin","year":"1989","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD002967-BIB255|cit255","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/diacare.21.10.1659","article-title":"Lactic acidosis rates in type 2 diabetes","volume":"21","author":"Brown","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB256|cit256","first-page":"105","article-title":"Metformin and the sulphonylureas: The comparative risk","volume":"15","author":"Campbell","year":"1985","journal-title":"Hormone and Metababolism Research Supplement"},{"key":"10.1002\/14651858.CD002967-BIB257|cit257","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1002\/dmr.5610110509","article-title":"Worldwide experience of metformin as an effective glucose-lowering agent: A meta-analysis","volume":"11 (Suppl 1)","author":"Campbell","year":"1995","journal-title":"Diabetes Metabolism Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002967-BIB258|cit258","first-page":"146A (Abs 455)","article-title":"Combined metformin\/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonylurea: Results of a mutlicenter trial","volume":"42","year":"1993","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD002967-BIB259|cit259","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"131","author":"DeFronzo","year":"1999","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002967-BIB260|cit260","first-page":"217","volume-title":"Statistical methods for rates and proportions","author":"Fleiss","year":"1981"},{"key":"10.1002\/14651858.CD002967-BIB261|cit261","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.1992.00400230129023","article-title":"Biguanide-assoicated lactic acidosis: case report and review of the literature","volume":"152","author":"Gan","year":"1992","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD002967-BIB262|cit262","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-5491.1999.00115.x","article-title":"Contra-indications to metformin therapy are largely disregarded","volume":"16","author":"Holstein","year":"1999","journal-title":"Diabetic Medicine"},{"key":"10.1002\/14651858.CD002967-BIB263|cit263","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"Part 1","key":"10.1002\/14651858.CD002967-BIB264|cit264","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-92-2-227","article-title":"Lactate homerostasis and lactic acidosis","volume":"92","author":"Kreisberg","year":"1980","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002967-BIB265|cit265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01263444","article-title":"Lactic acidosis in biguanide-treated diabetics: a review of 330 cases","volume":"14","author":"Luft","year":"1978","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD002967-BIB266|cit266","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199801223380415","article-title":"Lacic acidosis in patients with diabetes treated with metformin","volume":"338","author":"Misbin","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB267|cit267","first-page":"208","article-title":"Lactic acidosis","volume":"48","author":"Olivia","year":"1970","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD002967-BIB268|cit268","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1056-8727(97)00053-6","article-title":"Metformin: Effects of cardiovascular risk factors in patients with non-insulin-dependent diabetes mellitus","volume":"12","author":"Palumbo","year":"1998","journal-title":"Journal of Diabetes and its Complications"},{"issue":"5","key":"10.1002\/14651858.CD002967-BIB269|cit269","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD002967-BIB270|cit270","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1002\/14651858.CD002967-BIB271|cit271","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/1043-6618(94)80104-5","article-title":"Re-evaluation of a biguanide, metformin: mechanism of action and tolerability","volume":"30","author":"Sirtori","year":"1994","journal-title":"Pharmacology Research"},{"issue":"10","key":"10.1002\/14651858.CD002967-BIB272|cit272","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2337\/diacare.21.10.1587","article-title":"Matformin and lactic acidosis: guilt by association?","volume":"21","author":"Stacpoole","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB273|cit273","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.22.6.925","article-title":"Incidence of lactic acidosis in metformin users","volume":"22","author":"Stang","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB274|cit274","first-page":"625","article-title":"[Treatment of Diabetes mellitus with N.N. Dimethyl Guanil Guanidine (LA 6023, glucophage)]","volume":"14","author":"Sterne","year":"1959","journal-title":"Therapie"},{"issue":"15","key":"10.1002\/14651858.CD002967-BIB275|cit275","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology. A proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD002967-BIB276|cit276","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/diacare.20.6.925","article-title":"Contraindications to metformin therapy in patients with NIDDM","volume":"20","author":"Sulkin","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD002967-BIB277|cit277","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF02440866","article-title":"Metformin-associated lactic acidosis in Sweden 1977-1991","volume":"44","author":"Wilholm","year":"1993","journal-title":"European Journal of Clinical Pharmacology"}],"container-title":["The Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD002967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:14:28Z","timestamp":1628543668000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002967"}},"subtitle":[],"editor":[{"suffix":"MD","given":"Shelley","family":"Salpeter","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":277,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002967","relation":{},"subject":[],"published":{"date-parts":[[2003,7,21]]}}}